Insights into differential endostatin activity.
Maclachlan
Timothy K
TK
Department of Preclinical Development, CuraGen Corporation, 322 E. Main St., Branford, Connecticut 06405, USA. maclacht@hotmail.com
Dhanabal
Mohanraj
M
D020533:Angiogenesis Inhibitors / Q000378:metabolism / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D002454:Cell Differentiation / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D043169:Endostatins / Q000378:metabolism / Q000494:pharmacology*; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D018919:Neovascularization, Physiologic; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects; D014471:Umbilical Veins / Q000166:cytology / Q000187:drug effects
D020533:Angiogenesis Inhibitors; D043169:Endostatins